SIM
TEVA icon

Synergy Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Synergy Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57
Closed -$1.26K – 666
2024
Q4 		$1.26K Buy
+57
New +$1.04K ﹤0.01% 597

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Synergy Investment Management's TEVA Position: Q1 2025 in Review

Synergy Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 57 shares — an estimated $1.26K sold.

Synergy Investment Management first reported a position in TEVA in Q4 2024 and held it in 1 quarter. The position peaked at $1.26K in Q4 2024. 561 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Synergy Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Synergy Investment Management sold 57 Teva Pharmaceuticals shares in Q1 2025, an estimated $1.26K.
  • Synergy Investment Management first reported a position in Teva Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Synergy Investment Management's Teva Pharmaceuticals position peaked at $1.26K in Q4 2024.
  • 561 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Synergy Investment Management's 13F filing for Q1 2025, filed 30 Apr 2025.